See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Natural Disasters
Donald Trump
Social Media
Trade War
Stock Markets
Tennis
Artificial Intelligence
Trade
US Economy
Taxes
Published • loading... • Updated

Novo Holdings Wants to Do More China Biotech Deals, CEO Says

Summary by Bloomberg
Novo Holdings, the controlling shareholder of Danish weight-loss drug pioneer Novo Nordisk A/S, is seeking more biotech transactions in China following two deals last year for the overseas rights to experimental medicines.

1 Articles

All
Left
1
Center
Right
BloombergBloomberg
Lean Left

Novo Holdings Wants to Do More China Biotech Deals, CEO Says

Novo Holdings, the controlling shareholder of Danish weight-loss drug pioneer Novo Nordisk A/S, is seeking more biotech transactions in China following two deals last year for the overseas rights to experimental medicines.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Bloomberg broke the news in United States on Wednesday, April 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Novo Nordisk

Novo Nordisk

China

China

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal